Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Signed and dated informed consent form and medical release prior to any trial-specific procedures are performed * Females and males aged 18 years or older * Able to speak and read English * HbA1c between 6.5-8.9% (inclusive), tested within the past 30 days * Willing and able to visit a Quest Diagnostic Patient Service Center (PSC) * Willing and able to follow the trial instructions and Viome's Precision Nutrition Program * Willing and able to use a smartphone and Viome app. Exclusion Criteria: * Antibiotic use within one month of the GI test * Gestation within previous 6 month * Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.) * Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.) * On a specific diet, such as ketogenic, for the purpose of reducing HbA1c and/or weight within the previous month * Taking diet pills * Allergy to an ingredient in the MH capsule or stick pack * Currently on an investigational product * Significant surgery or medical procedure planned * Diet or lifestyle change during the trial period, besides those appropriate for trial arm Has followed Viome nutritional recommendations (foods and/or supplements)
About the study
This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.
What is being tested
- Viome's Precision Nutrition Program (VPNP) (dietary supplement)
Sponsor: Viome · Participants: 100 · Started: Dec 13, 2023
Contact the study team
- Mory Mehrtash · Phone: (425) 300-6933
- Momchilo Vuyisich · Phone: (425) 300-6933
Official record on ClinicalTrials.gov — NCT06185192
Locations in the U.S.
| Washington | Viome Life Sciences, Bothell |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.